Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs

Daiichi Sankyo Global R&D Head Glenn Gormley Daiichi Sankyo hopes to see eight to 10 research projects enter the clinical development stage each year throughout its five year business plan ending 2017, Glenn Gormley, global head of R&D, said on...read more